Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.
- Published In:
- Journal of molecular neuroscience : MN, 68(3), 397-407 (2019)
- Authors:
- Atlasz, Tamas, Werling, D, Song, S, Szabo, E, Vaczy, A, Kovari, P, Tamas, A, Reglodi, D, Yu, Rongjie
- Database ID:
- RPEP-04059
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04059APA
Atlasz, Tamas; Werling, D; Song, S; Szabo, E; Vaczy, A; Kovari, P; Tamas, A; Reglodi, D; Yu, Rongjie. (2019). Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.. Journal of molecular neuroscience : MN, 68(3), 397-407. https://doi.org/10.1007/s12031-018-1229-5
MLA
Atlasz, Tamas, et al. "Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide.." Journal of molecular neuroscience : MN, 2019. https://doi.org/10.1007/s12031-018-1229-5
RethinkPeptides
RethinkPeptides Research Database. "Retinoprotective Effects of TAT-Bound Vasoactive Intestinal ..." RPEP-04059. Retrieved from https://rethinkpeptides.com/research/atlasz-2019-retinoprotective-effects-of-tatbound
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.